Duration of Study. Principal Investigator expects to complete Study conduct by April 30, 2018. If required, the Study must be approved by CMT should an extension past April 30, 2018 to complete the Study is needed.
Appears in 2 contracts
Sources: Clinical Trial Agreement (Creative Medical Technology Holdings, Inc.), Clinical Trial Agreement (Creative Medical Technology Holdings, Inc.)